Posted in | News | Energy

Demonstration of New Explosives and Drug Detection Technology Planned

VIASPACE Inc. (OTC Bulletin Board: VSPC) an alternative energy company with subsidiary operations in security technology, is planning a mid-May 2009 field demonstration of its high-sensitivity system for detecting and analyzing chemical, explosive, and drug residues in suspect vessels.

The demonstration is part of a competitively selected/awarded phase II contract for two years and up to $786,000 in funding.

Through its subsidiary Ionfinity, VIASPACE is developing a sensitive miniaturized "sniffer" in a joint collaboration with NASA's Jet Propulsion Laboratory, Caltech, General Dynamics, Sionex, and Imaginative Technologies. The development project, entitled "Miniature Electronic Sniffer for Navy Vertical Take off Unmanned Aerial Vehicles (VTUAVs)" was awarded by the U.S. Navy's Small Business Technology Transfer (STTR) Program.

Ionfinity Chairman, Chief Operating Officer and Principal Investigator James Weiss said: " We believe the new sensor we will demonstrate will substantially raise the standard for future chemical detection and analysis and at the same time make the process much more convenient and timely. "

Weiss added that while Ionfinity's new sensor technology has direct application in the $55 billion security industry, it is also expected to have commercial applications in environmental monitoring, agriculture and medicine.

According to the Company, the sensor is a compact stand-alone chemical device consisting of: 1) a new and powerful detector called a Differential Mobility Spectrometer; 2) a non-radioactive ionization method that does not fragment or multiply-ionize sampled specimens; and 3) a micro-gas chromatograph for confirmation and enhanced detection capability. The device will detect chemicals and materials of interest at parts-per-billion (ppb) levels after 6 seconds. The sensor is self contained with respect to power and communications.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.